IP Library Granted Patent US 12,167,743
Granted Patent B2
US 12,167,743 · App. 17/752,706 · Granted Dec 17, 2024

Oral product

Inventors: Feng Gao (Midlothian, VA); Frank Scott Atchley (Tarpon Springs, FL); Gregory James Griscik (Midlothian, VA); Christopher Joseph Dinovi (Ruther Glen, VA); Phillip M. Hulan (Midlothian, VA); Diane L. Gee (Chesterfield, VA); Jason Flora (Richmond, VA); Shuzhong Zhuang (Glen Allen, VA)
Assignee: Altria Client Services LLC
A24B15/10A24B13/00A24B15/16A61K31/465
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,167,743
App. No.
17/752,706
Granted
Dec 17, 2024
Kind
B2
Abstract

An oral product includes a body that is wholly receivable in an oral cavity. The body includes a mouth-stable polymer matrix, cellulosic fibers embedded in the mouth-stable polymer matrix, and nicotine or a derivative thereof dispersed in the mouth-stable polymer matrix. The oral product is adapted to release the nicotine or derivative thereof from the body when the body is received within the oral cavity and exposed to saliva.

Claims (30)

1. An oral product comprising:

a polymer matrix including,

a mouth-stable polymer;

a cellulosic material;

nicotine or a nicotine derivative; and

medium chain triglycerides, the oral product having a compressibility at 250 N ranging from 45% to 95% and a springiness of greater than or equal to 60%.

2. The oral product of claim 1 , wherein the mouth-stable polymer has a flexural modulus of greater than or equal to 5 MPa, a tensile strength of greater than or equal to 10 MPa, and an ultimate elongation of less than 100%.

3. The oral product of claim 1 , wherein the mouth-stable polymer has a Shore Hardness of 50D or softer.

4. The oral product of claim 1 , wherein the mouth-stable polymer includes a thermoplastic elastomer.

5. The oral product of claim 1 , wherein the cellulosic material includes a treated cellulosic material.

6. The oral product of claim 1 , wherein the cellulosic material includes microcrystalline cellulose.

7. The oral product of claim 1 , wherein the cellulosic material includes sugar beet fibers, wood pulp fibers, cotton fibers, bran fibers, citrus pulp fibers, grass fibers, willow fibers, poplar fibers, or any combination thereof.

8. The oral product of claim 1 , wherein the cellulosic material is present in an amount greater than 10 weight percent of the oral product.

9. The oral product of claim 1 , wherein the oral product has a compressibility at 425 N ranging from 60% to 98%.

10. The oral product of claim 1 , wherein the mouth-stable polymer is present in an amount greater than 40 weight percent of the oral product.

11. The oral product of claim 1 , wherein the mouth-stable polymer is present in an amount greater than 80 weight percent of the oral product.

12. The oral product of claim 1 , further comprising:

soluble fibers configured to dissolve to form channels in the polymer matrix.

13. The oral product of claim 12 , wherein the soluble fibers include maltodextrin.

14. The oral product of claim 1 , further comprising:

an additive including a mineral, a vitamin, a dietary supplement, a nutraceutical, an energizing agent, a soothing agent, an amino acid, a chemesthetic agent, an antioxidant, botanical, a teeth whitening agent, a therapeutic agent, or any combination thereof.

15. The oral product of claim 1 , further comprising:

a sweetener including saccharine, sucralose, aspartame, acesulfame potassium, or any combination thereof.

16. The oral product of claim 1 , further comprising:

a flavorant including licorice, wintergreen, cherry and berry type flavorants, Drambuie, bourbon, scotch, whiskey, spearmint, peppermint, lavender, cinnamon, cardamon, apium graveolens, clove, cascarilla, nutmeg, sandalwood, bergamot, geranium, honey essence, rose oil, vanilla, lemon oil, orange oil, Japanese mint, cassia, caraway, cognac, jasmine, chamomile, menthol, ylang-ylang, sage, fennel, pimenta, ginger, anise, coriander, coffee, mint oils from a species of the genus Mentha, or any combination thereof.

17. The oral product of claim 1 , further comprising:

an antioxidant the antioxidant including ascorbyl palmitate, BHT, ascorbic acid, sodium ascorbate, monosterol citrate, tocopherols, propyl gallate, tertiary butylhydroquinone (TBHQ), butylated hydroxyanisole (BHA), Vitamin E, or any combination thereof.

18. The oral product of claim 1 , wherein the nicotine or nicotine derivative includes tobacco-derived nicotine.

19. The oral product of claim 1 , wherein the nicotine or nicotine derivative includes synthetic nicotine.

20. The oral product of claim 1 , wherein the oral product includes the nicotine or nicotine derivative in an amount ranging from 0.1 to 6 mg.

Continuity (6)
Continuation 16881627 · May 22, 2020
Continuation 15816506 · Nov 17, 2017
Continuation 13744930 · Jan 18, 2013
Provisional Application 61720852 · Oct 31, 2012
Provisional Application 61588873 · Jan 20, 2012
Related Publication 20220279834A1 · Sep 8, 2022